Highly potent API and ADC payload and payload-linker manufacturing

Highly potent API and ADC payload and payload-linker manufacturing

Products
Highly potent API and ADC payload and payload-linker manufacturing
Highly potent API and ADC payload and payload-linker manufacturing

Information

WuXi STA's Jinshan site and WuXi STA's Changzhou site are equipped with a R&D labs, a cGMP HP Kilo lab, and cGMP plant for handling highly potent APIs (HPAPIs) and antibody drug conjugate (ADC) payloads and payload-linkers. We offer drug product manufacturing at STA's Shanghai Waigaoqiao site and soon our Wuxi city site. These facilities offer containment level down to an OEL limit of 0.05 μg/m³. Our teams have the expertise and track records operating equipment under rigorous handling procedures for HPAPIs, ADC payloads and payload-linkers for global clients
Main Categories
BiopharmaceuticalsAPIs (Active Pharmaceutical Ingredients)
All Categories
BiopharmaceuticalsAPIs (Active Pharmaceutical Ingredients)Antibody Drug Conjugates (ADCs)
WuXi STAWuXi STA, a subsidiary of WuXi AppTec, is a leading CRDMO providing integrated CMC services including both API and drug product for small molecule, oligonucleotide, peptide and complex conjugate from discovery to development and commercial manufacturing. We have 14 R&D and manufacturing sites across Asia, North America and Europe.

Log in

See all the content and easy-to-use features by logging in or registering!